Physician profile
Kelli E Daniels
NPI 1750321485
$1,094.49
in general payments reported to CMS, 2019-2025
14 companies · $77.39 in 2025
The $77.39 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $92.96 · 2021: $512 · 2022: $93.82 · 2023: $304 · 2024: $14.25 · 2025: $77.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $257 · Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $256.98 |
| Food and Beverage | $138.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $475.57 | 2021 | |
| Astellas Pharma US INC | $274.30 | 2023-2025 | Veozah |
| Abbvie INC. | $56.74 | 2020-2022 | |
| Ethicon US, LLC | $46.75 | 2020 | |
| Hologic Sales and Service, LLC | $44.23 | 2021-2025 | Aptima |
| Pfizer INC. | $33.29 | 2022 | |
| Medtronic, INC. | $29.95 | 2023 | Truclear |
| Myovant Sciences INC. | $25.75 | 2022 | |
| Davol INC. | $20.49 | 2022 | |
| Smith+Nephew, INC. | $19.94 | 2025 | Pico 14 |
| Coopersurgical, INC. | $18.47 | 2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $17.73 | 2020 | |
| Merck Sharp & Dohme LLC | $17.03 | 2023 | Gardasil 9 |
| Organon LLC | $14.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.